Member Registration

Members of LabOps Unite: please register here.
Members of BioCT: please register here.
Members of MassBio: please register on this page.

Want your organization to gain access to member rates?  Email courses@massbioed.org for more information.

Rates & Funding

Please view the discount options for courses before registering here.

Intro to Biotech Package (Business + Science) Member Rate: $1,550
Intro to Biotech Package (Business + Science) Non-Member Rate: $1,800
Business OR Science Member Rate: $850
Business OR Science Non-Member Rate: $1,025

Deadline to apply to the WTFP Express Program: March 4, 2026.
Course ID: C-2692

Single Company Offerings

Interested in offering this training exclusively to your team?
Email courses@massbioed.org to learn more.

Description

Intro to Biotech, Business & Science provides a comprehensive introduction to both the business and scientific foundations of the biotechnology and life sciences industry. Designed to offer a big-picture understanding of how biotech organizations operate, the course can be taken as a combined experience or as standalone Business or Science modules, depending on participants’ interests and goals.

The Business portion introduces core business considerations in biotech, including regulation, market dynamics, phases of development, patient populations, and safety profiles. Through instruction, real-world storytelling, and small-group discussion, participants gain insight into how strategic and regulatory decisions shape biotech companies.

The Science portion focuses on foundational biological concepts, including cell biology and molecular biology, to support a deeper understanding of how life science companies function. Participants explore key scientific principles that underpin drug discovery and development, with hands-on lab work included during in-person sessions to reinforce learning and practical application.

Together, these modules provide participants with a well-rounded framework for understanding how science, business, and regulation intersect across the biotech ecosystem.

Who should attend? This course is designed for a broad audience, including individuals who are new to the biotechnology or life sciences industry, those transitioning from another scientific or professional field, and professionals seeking a stronger foundational understanding of either the business, the science, or both. It is particularly well suited for participants who want to understand how their role fits into the larger biotech landscape and how scientific innovation moves from concept to organization and market.

Participants looking to deepen their understanding of the biotech industry may benefit from Finance of Biotechnology, Drug Development Pathways, or Biotechnology Project Management, which expand on financial decision-making, the drug development lifecycle, and project execution within life sciences organizations.

Schedule

Business

Thursday, March 26, 2026 | 9:00 AM – 11:30 AM EST
Thursday, April 2, 2026 | 9:00 AM – 11:30 AM EST
Thursday, April 9, 2026 | 9:00 AM – 11:30 AM EST

Science
Thursday, April 16, 2026 | 9:00 AM – 11:30 AM EST
Thursday, April 23, 2026 | 9:00 AM – 11:30 AM EST
Thursday, April 30, 2026 | 9:00 AM – 11:30 AM EST

Meet the Instructors

Business Instructors

John Tagliamonte
SVP, Business Development, Tract Bio

John Tagliamonte has more than 30 years of executive leadership experience across public and private life sciences companies, with expertise in business development, finance, commercial operations, strategic planning, and legal functions. As MassBio’s first Entrepreneur-in-Residence, he helped shape forward-looking program content while mentoring the next generation of biotech entrepreneurs.

Atul Deshpande, Ph.D., MBA
CEO, IMMEDIATE Therapeutics
Atul Deshpande is the Chief Executive Officer of IMMEDIATE Therapeutics, a clinical-stage biotech company dedicated to developing safe and effective therapeutic solutions to reduce heart muscle damage and prevent cardiac arrest in Acute Coronary Syndromes. Previously, he served as Chief Strategy Officer at Peptilogics and led Asia Pacific R&D strategy efforts for Sanofi in China.

Science Instructor

Sowmya Chary, MD, MMSc
Senior Medical Director, Clinical Development, Dyne Therapeutics

Sowmya Chary is a Senior Medical Director of Clinical Development at Dyne Therapeutics and a Faculty Course Director at Harvard Medical School. She brings a background in medicine, clinical research, and industry to her teaching, with training from Sri Ramachandra University in India and a Master of Medical Sciences in Clinical Investigation from Harvard Medical School. A passionate educator and mentor, Sowmya creates an engaging and collaborative learning environment that helps participants connect scientific principles to real-world biotech and pharmaceutical careers.